Page last updated: 2024-11-01

ondansetron and Psychoses, Drug

ondansetron has been researched along with Psychoses, Drug in 3 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
" In the prelevodopa era, depression and other psychiatric disorders were described in PD, but in untreated patients psychosis was rare."4.79Parkinson's disease: drug-induced psychiatric states. ( Brown, D; Factor, SA; Molho, ES; Podskalny, GD, 1995)
"Ondansetron did not cause any worsening in basic PD symptoms or levodopa efficacy and was well tolerated with no major side effects."2.68Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist. ( Friedberg, G; Livneh, M; Melamed, E; Zoldan, J, 1995)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zoldan, J1
Friedberg, G1
Livneh, M1
Melamed, E1
Factor, SA1
Molho, ES1
Podskalny, GD1
Brown, D1
Eichhorn, TE1
Brunt, E1
Oertel, WH1

Reviews

1 review available for ondansetron and Psychoses, Drug

ArticleYear
Parkinson's disease: drug-induced psychiatric states.
    Advances in neurology, 1995, Volume: 65

    Topics: Aged; Anxiety; Bipolar Disorder; Clozapine; Depression; Electroconvulsive Therapy; Humans; Levodopa;

1995

Trials

1 trial available for ondansetron and Psychoses, Drug

ArticleYear
Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist.
    Neurology, 1995, Volume: 45, Issue:7

    Topics: Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Ondansetron; Parkinson Disease; Psychose

1995

Other Studies

1 other study available for ondansetron and Psychoses, Drug

ArticleYear
Ondansetron treatment of L-dopa-induced psychosis.
    Neurology, 1996, Volume: 47, Issue:6

    Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Ondansetron; Psychoses, Substance-Induced

1996